CORRESP Filing
LB PHARMACEUTICALS INC
Date: Sept. 9, 2025 · CIK: 0001691082 · Accession: 0001193125-25-198853
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289812
Letter
Re: LB Pharmaceuticals Inc Registration Statement on Form S-1, as amended (Registration No. 333-289812) Ladies and Gentlemen: In connection with the above-referenced Registration Statement, as amended, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), we hereby join in the request of LB Pharmaceuticals Inc that the effective date of the Registration Statement, as amended, be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on September 10, 2025, or as soon thereafter as practicable. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others prior to the requested effective time of the Registration Statement. In connection with the preliminary prospectus distribution for the above-referenced issue, the prospective underwriters have confirmed that they are complying with the 48-hour requirement in Rule 15c2-8(b) under the Securities Exchange Act of 1934, as amended. Very truly yours, LEERINK PARTNERS LLC PIPER SANDLER & CO. STIFEL, NICOLAUS & COMPANY, INCORPORATED As Representatives of the several underwriters [SIGNATURE PAGE FOLLOWS]
September 9, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549
Attention: Christine Torney
Mary Mast
Doris Stacey Gama
Laura Crotty
LEERINK PARTNERS LLC
By:
/s/ Rahul Chaudhary
Name: Rahul Chaudhary
Title: Senior Managing Director, Head of Equity Capital Markets
PIPER SANDLER & CO.
By:
/s/ Chad Huber
Name: Chad Huber
Title: Managing Director
STIFEL, NICOLAUS & COMPANY, INCORPORATED
By:
/s/ Ken Clausman
Name: Ken Clausman
Title: Managing Director As representatives of the several underwriters.
[Signature Page to Acceleration Request Letter]
Show Raw Text
CORRESP 1 filename1.htm CORRESP September 9, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Christine Torney Mary Mast Doris Stacey Gama Laura Crotty Re: LB Pharmaceuticals Inc Registration Statement on Form S-1, as amended (Registration No. 333-289812) Ladies and Gentlemen: In connection with the above-referenced Registration Statement, as amended, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), we hereby join in the request of LB Pharmaceuticals Inc that the effective date of the Registration Statement, as amended, be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on September 10, 2025, or as soon thereafter as practicable. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others prior to the requested effective time of the Registration Statement. In connection with the preliminary prospectus distribution for the above-referenced issue, the prospective underwriters have confirmed that they are complying with the 48-hour requirement in Rule 15c2-8(b) under the Securities Exchange Act of 1934, as amended. Very truly yours, LEERINK PARTNERS LLC PIPER SANDLER & CO. STIFEL, NICOLAUS & COMPANY, INCORPORATED As Representatives of the several underwriters [SIGNATURE PAGE FOLLOWS] LEERINK PARTNERS LLC By: /s/ Rahul Chaudhary Name: Rahul Chaudhary Title: Senior Managing Director, Head of Equity Capital Markets PIPER SANDLER & CO. By: /s/ Chad Huber Name: Chad Huber Title: Managing Director STIFEL, NICOLAUS & COMPANY, INCORPORATED By: /s/ Ken Clausman Name: Ken Clausman Title: Managing Director As representatives of the several underwriters. [Signature Page to Acceleration Request Letter]